Elastomeric Infusion Pumps Market Outlook 2026-2030: Growth Drivers, Trends, and Strategic Insights with Expert Review

The Elastomeric Infusion Pumps Market is witnessing steady growth, driven by rising demand for ambulatory care, home-based treatments, and cost-effective drug delivery systems. Their portability, ease of use, and reduced need for electronic components make them ideal for pain management and chemotherapy, positioning the market for sustained expansion across healthcare settings.
The global elastomeric infusion pumps market, valued at US$1.09 billion in 2024, stood at US$1.15 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.49 billion by the end of the period. This market research report provides access to critical information such as elastomeric infusion pumps market growth [https://www.marketsandmarkets.com/Market-Reports/elastomeric-infusion-pumps-market-10422815.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=elastomericinfusionpumps] drivers, market growth restraints, current market trends, the market's economic and financial structure, and other key market details. Elastomeric infusion pumps are advanced, non-electronic medical devices that enable controlled, continuous drug delivery in home care, hospice, and ambulatory settings. These devices are commonly used in the management of oncology, pain management, and palliative care, providing a safe, accurate, and portable alternative to conventional infusion systems. In the United States, every year, there are around 2 million new cancer cases, with more than 600,000 deaths expected in 2024, which demonstrates the immediate need for safe and effective delivery of pharmaceuticals for these patients.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=elastomericinfusionpumps]

The use of elastomeric infusion pumps helps patients requiring extended and continuous chemotherapy, analgesics, and palliative care. The use of elastomeric infusion pumps provides a modern means to promote mobility, independence, and adherence to treatment plans. Today's elastomeric pumps are designed to be simple and safe to use with anti-free-flow mechanisms, customizable flow rates, and biocompatible materials that maintain the stability of the pharmaceutical. Regulatory oversight from the U.S. FDA and the European Medicines Agency (EMA) ensures the accuracy, sterility, and quality of these infusion pumps, which ultimately allows our healthcare system to treat patients in a patient-centered way and is an important component of treating patients in today's world of oncology and chronic disease management.

Chemotherapy is expected to be the second-fastest-growing application during the forecast period.

Chemotherapy is projected to be the second-fastest-growing application for elastomeric infusion pumps during the forecast period, driven by the rising global incidence of cancer and the increasing demand for outpatient and home-based treatments. These pumps enable precise, continuous, and controlled delivery of chemotherapeutic drugs, minimizing hospital visits while improving patient comfort and adherence to treatment schedules. Advances in pump design, such as lightweight, portable, and easy-to-use systems, further support their adoption in oncology care. Moreover, the growing awareness of personalized cancer therapies and targeted drug delivery is encouraging healthcare providers to integrate elastomeric pumps into chemotherapy protocols, thereby enhancing treatment efficiency and improving patient quality of life.

Ambulatory Surgical Centers (ASCs) are expected to be the second-fastest-growing end-use industry during the forecast period

Ambulatory Surgical Centers (ASCs) will likely be the second-fastest-growing end-use industry for elastomeric infusion pumps. The increasing acceptance of outpatient surgeries will drive growth, as they offer cost-effective and convenient options with shorter recuperation times compared to the hospital environment. Elastomeric pumps offer ASCs convenient, portable, and easy-to-use solutions for drug administration, providing consistent and accurate delivery without the need for lengthy hospital stays. Furthermore, increased patient awareness, advancements in minimally invasive procedures, and favorable reimbursement guidelines are driving the introduction of these pumps in ASCs.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=10422815

North America is expected to be the second-fastest-growing region during the forecast period.

North America is expected to be the second-fastest-growing region during the projection period, driven by strong economic activity, technological innovations, and increasing investments across various sectors. The region's expansion is driven by robust consumer demand, especially in the United States, where advancements in sectors such as technology, healthcare, and renewable energy are crucial. Canada and Mexico also play a substantial role, with their manufacturing and trade networks expanding. Supportive government action, infrastructure expansion, and a highly skilled workforce complement the region's economic momentum.

Elastomeric Infusion Pump Companies

The report profiles key companies, including Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), and WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan).

About MarketsandMarkets Trademark

MarketsandMarkets Trademark has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets Trademark is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore Trademark , which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets Trademark .com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=elastomeric-infusion-pumps-market-outlook-20262030-growth-drivers-trends-and-strategic-insights-with-expert-review]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/elastomeric-infusion-pumps-market-10422815.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.